Immune response, depression and fatigue in relation to support intervention in mammary cancer patients

Supportive Care in Cancer

Volumn 16, Issue 1, 2008, Pages 57-65

  Lindemalm, Christina ^a   Mozaffari, Fariba ^a   Choudhury, Aniruddha ^a   Granstam Björneklett, Helena ^b   Lekander, Mats ^c   Nilsson, Bo ^a   Ojutkangas, Marja Leena ^d   Österborg, Anders ^a   Bergkvist, Leif ^b,d   Mellstedt, Håkan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Depression; Immunology; NK cells; NK cytotoxicity; Support group intervention

Indexed keywords

ANTIGEN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ANXIETY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DEPRESSION; FATIGUE; FEMALE; FLOW CYTOMETRY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IMMUNE RESPONSE; INTERVENTION STUDY; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER T CELL; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANXIETY; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DEPRESSION; FATIGUE; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; SELF-HELP GROUPS; SIGNAL TRANSDUCTION;

EID: 36949022871     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0275-2     Document Type: Article

References (50)

1. Ader R (2000) On the development of psychoneuroimmunology. Eur J Pharmacol 405(13):167-176
2. Ahles TA, Saykin AJ (2002) Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 3(Suppl 3):S84-S90
3. Andersen BL (2002) Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol 70(3):590-610
4. Andersen BL, Farrar WB, Golden-Kreutz DM, Glaser R, Emery CF, Crespin TR, Shapiro CL, Carson WE 3rd (2004) Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol 22(17):3570-3580
5. Antoni MH (2003) Psychoneuroendocrinology and psychoneuroimmunology of cancer: plausible mechanisms worth pursuing? Brain Behav Immun 17(Suppl 1):S84-S91
6. Beitsch P, Lotzova E, Hortobagyi G, Pollock R (1994) Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery. Surg Oncol 3(4):211-219
7. Brenner BG, Margolese RG (1991) The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer. Cancer 68(3):482-488
8. Brown KW, Levy AR, Rosberger Z, Edgar L (2003) Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med 65:636-643
9. Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, Neveu PJ (2001) Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26(8):797-808
10. Carlson LE, Speca M, Patel KD, Goodey E (2003) Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 65(4):571-581
11. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP (1993) Development of a fatigue scale. J Psychosom Res 37(2):147-153
12. Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R (1994) Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol 13(4):291-298
13. Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, Morton DL (1993) Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50(9):681-689
14. Fawzy FI, Canade AC, Fawy NW (2003) Malignant melanoma effects of a brief structured psychiatric intervention on survival and recurrence at 10 years follow-up. Arch Gen Psychiatry 60(1):100-103
15. Focan C (1995) Relevance of circadian cell kinetics in the timing of chemotherapy in animal tumors. In Vivo 9(6):573-581
16. Given C, Given B, Rahbar M, Jeon S, McCorkle R, Cimprich B, Galecki A, Kozachik S, Brady A, Fisher-Malloy MJ, Courtney K, Bowie E (2004) Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol 22(3):507-516
17. Heim ME, Kunert S, Ozkan I (2001) Effects of inpatient rehabilitation on health-related quality of life in breast cancer patients. Onkologie 24(3):268-272
18. Kuppen PJ, Basse PH, Goldfarb RH, Van de Velde CJ, Fleuren GJ, Eggermont AM (1994) The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in WAG rats. Int J Cancer 56(4):574-579
19. Larson MR, Duberstein PR, Talbot NL, Caldwell C, Moynihan JA (2000) A presurgical psychosocial intervention for breast cancer patients. Psychological distress and the immune response. J Psychosom Res 48(2):187-194
20. Lekander M, Furst CJ, Rotstein S, Hursti TJ, Fredrikson M (1997) Immune effects of relaxation during chemotherapy for ovarian cancer. Psychother Psychosom 66(4):185-191
21. Levy SM, Herberman RB, Whiteside T, Sanzo K, Lee J, Kirkwood J (1990) Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med 52(1):73-85
22. Lindemalm C, Strang P, Lekander M (2005) Support group for cancer patients. Does it improve their physical and psychological well-being? A pilot study. Support Care Cancer 13(8):652-657
23. Lister J, Rybka WB, Donnenberg AD, deMagalhaes-Silverman M, Pincus SM, Bloom EJ, Elder EM, Ball ED, Whiteside TL (1995) Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cell transplantation in the immediate posttransplant period. Clin Cancer Res 1(6):607-614
24. Loge JH, Ekeberg O, Kaasa S (1998) Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res 45(1):53-65
25. Lukac J, Kusic Z, Kordic D, Koncar M, Bolanca A (1994) Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 29(3):279-285
26. Maguire GP, Lee EG, Bevington DJ, Kuchemann CS, Crabtree RJ, Cornell CE (1978) Psychiatric problems in the first year after mastectomy. Br Med J 1(6118):963-965
27. McCulloch PG, MacIntyre A (1993) Effects of surgery on the generation of lymphokine-activated killer cells in patients with breast cancer. Br J Surg 80(8):1005-1007
28. Morse R, Rodgers J, Verrill M, Kendell K (2003) Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review. Eur J Cancer 39(16):2288-2297
29. Montazeri A, Jarvandi S, Haghighat S, Vahdani M, Sajadian A, Ebrahimi M, Haij-Mahmoodi M (2001) Anxiety and depression in breast cancer patients before and after participation in a cancer support group. Patient Educ Couns 45:195-198
30. Murta EF, de Andrade JM, Falcao RP, Bighetti S (2000) Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumori 86(5):403-407
31. Nicolini A, Ferrari AP, Spinelli R, Carpi A, Sagripanti A, Ambrogi F (1996) Cell-mediated immunity in breast cancer patients. Biomed Pharmacother 50(8):337-343
32. Oldervoll LM, Kaasa S, Knobel H, Loge JH (2003) Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors-results from a pilot study. Eur J Cancer 39(1):57-63
33. Pickett M, Mock V, Ropka ME, Cameron L, Coleman M, Podewils L (2002) Adherence to moderate-intensity exercise during breast cancer therapy. Cancer Pract 10(6):284-292
34. Rakhmilevich AL, Janssen K, Hao Z, Sondel PM, Yang NS (2000) Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism. Cancer Gene Ther 7(6):826-838
35. Richardson MA, Post-White J, Grimm EA, Moye LA, Singletary SE, Justice B (1997) Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment. Altern Ther Health Med 3(5):62-70
36. Ryu H, Jun CD, Lee BS, Choi BM, Kim HM, Chung HT (1995) Effect of qigong training on proportions of T lymphocyte subsets in human peripheral blood. Am J Chin Med 23(1):27-36
37. Sabbioni ME, Siegrist HP, Bacchi M, Bernhard J, Castiglione M, Thurlimann B, Bonnefoi H, Perey L, Herrmann R, Goldhirsch A, Hurny C (2000) Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment. Breast Cancer Res Treat 59(3):279-287
38. Schule J, Bergkvist L, Hakansson L, Gustafsson B, Hakansson A (2002) Down-regulation of the CD3-zeta chain in sentinel node biopsies from breast cancer patients. Breast Cancer Res Treat 74(1):33-40
39. Schule JM, Bergkvist L, Hakansson L, Gustafsson B, Hakansson A (2004) CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression. J Transl Med 2(1):45
40. Sellick SM, Crooks DL (1999) Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions. Psychooncology 8(4):315-333
41. Servaes P, Verhagen C, Bleijenberg G (2002) Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38:27-43
42. Solomayer EF, Feuerer M, Bai L, Umansky V, Beckhove P, Meyberg GC, Bastert G, Schirrmacher V, Diel IJ (2003) Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer. Clin Cancer Res 9(1):174-180
43. Spiegel D (2001) Mind matters. Coping and cancer progression. J Psychosom Res 50(5):287-290
44. Stark DP, House A (2000) Anxiety in cancer patients. Br J Cancer 83(10):1261-1267
45. van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90(3):210-218
46. van der Pompe G, Duivenvoorden HJ, Antoni M, Visser A, Heijman CJ (1997) Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study. J Psychosom Res 42(5):453-466
47. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM (1999) Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 354(9187):1331-1336
48. Whiteside TL, Herberman RB (1995) The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol 7(5):704-710
49. Whiteside TL (2003) Immune responses to malignancies. J Allergy Clin Immunol 111(2):677-686
50. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361-370